About 1,925 results

ALLMedicine™ Kaposi Sarcoma Center

Research & Reviews  695 results

International survey of human herpes virus 8 screening and management in solid organ tr...
Transplant Infectious Disease : an Official Journal of Th... Alessandra M, Mikulska M et. al.

Jul 30th, 2021 - HHV-8/Kaposi Sarcoma herpesvirus (KSHV) has been associated with a broad spectrum of diseases in solid organ transplant (SOT) recipients. Primary donor-derived infection can be associated with severe and rapidly fatal non-neoplastic disease, and d...

Diffuse dermal angiomatosis of the breast: an emerging entity in the setting of cutaneo...
Clinics in Dermatology; Ferreli C, Atzori L et. al.

Jul 18th, 2021 - New and emerging types of cutaneous vascular (capillary) proliferations have been described or better categorized in the last few years. They include reactive angioendotheliomatosis, acroangiodermatitis (pseudo-Kaposi sarcoma), diffuse dermal angi...

Clinical characteristics and successful treatment outcomes of children and adolescents ...
Pediatric Hematology and Oncology; Campbell LR, El-Mallawany NK et. al.

Jul 11th, 2021 - The HIV/AIDS epidemic has driven the rise in cases of Kaposi sarcoma (KS) among children and adolescents living with HIV in countries with high Human gammaherpesvirus 8 (HHV-8) seroprevalence, such as Tanzania, where specialized oncology programs ...

Nodular Endemic Kaposi Sarcoma Successfully Treated With Mohs Micrographic Surgery.
Dermatologic Surgery : Official Publication for American ... Rigo R, Lee A et. al.

Jul 8th, 2021 - Nodular Endemic Kaposi Sarcoma Successfully Treated With Mohs Micrographic Surgery.|2021|Rigo R,Lee A,Minkis K,|

see more →

Drugs  2 results see all →

Clinicaltrials.gov  14 results

Pembrolizumab in Treating Patients With HIV and Relapsed, Refractory, or Disseminated Malignant Neoplasms

Apr 10th, 2020 - PRIMARY OBJECTIVES: I. To assess the safety and tolerability of MK-3475 (pembrolizumab) in HIV-infected patients on effective antiretroviral therapy and with relapsed/refractory or disseminated acquired immune deficiency syndrome (AIDS)-defining o...

Intra-lesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma

Nov 18th, 2019 - Infection with Kaposi sarcoma herpesvirus (KSHV, or human herpesvirus-8 [HHV-8]) causes Kaposi sarcoma (KS). These virally associated diseases occur more frequently in HIV-infected individuals, but can also be found in HIV-uninfected population. E...

Valganciclovir Four Weeks Prior to cART Initiation Compared to Standard Therapy for Disseminated Kaposi Sarcoma

Mar 14th, 2019 - Kaposi sarcoma (KS) is an angioproliferative disease associated with infection by the Human Immune Deficiency virus (HIV), mediated by cytokines, in which the presence of Human Herpes-Virus 8 (HHV-8) and immunosuppression are essential for the dis...

Nivolumab and Ipilimumab in Classical Kaposi Sarcoma (CKS)

Dec 26th, 2018 - A prospective, single arm, interventional study. All patients will receive IV nivolumab 3mg/kg every two weeks and ipilimumab 1mg/kg every 6 weeks. Patients will be treated until disease progression or intolerable toxicity for a maximal period of ...

History of the KSHV Inflammatory Cytokine Syndrome (KICS)

Oct 15th, 2018 - BACKGROUND: KSHV inflammatory cytokine syndrome (KICS) is a newly recognized syndrome caused by Kaposi sarcoma-associated herpesvirus (KSHV). It is characterized by severe inflammatory symptoms including fevers, wasting, cytopenias, hypoalbuminemi...

see more →

News  54 results

FDA Approves Pomalidomide for Kaposi Sarcoma

May 15th, 2020 - The US Food and Drug Administration (FDA) has granted accelerated approval to pomalidomide (Pomalyst, Bristol-Myers Squibb) for the treatment of AIDS-related Kaposi sarcoma that is resistant to highly active antiretroviral therapy (HAART) or that ...

Less pain with a cancer drug to treat anal HPV, but it’s expensive
M. Alexander Otto

Mar 26th, 2020 - At the end of 6 months of low-dose pomalidomide (Pomalyst), more than half of men who have sex with men had partial or complete clearance of long-standing, grade 3 anal lesions from human papillomavirus, irrespective of HIV status; the number incr.

Not So Classic, Classic Kaposi Sarcoma
Maggie L. Chow, MD, PhD, Ashley J. Crew, MD et. al.

Feb 24th, 2020 - To the Editor: Kaposi sarcoma (KS) is a lymphatic endothelial cell neoplasm that frequently presents as multiple vascular cutaneous and mucosal nodules. 1 The classic KS variant typically is described as the presentation of KS in otherwise healthy.

Infections Account for 13% of All Cancer Cases

Jan 21st, 2020 - An estimated 13% of all cancer cases in 2018 may be attributable to infections, concludes a new global survey. This extrapolates to about 2.2 million cancer cases that were diagnosed worldwide, corresponding to an age-standardized incidence rate (...

Kaposi Sarcoma in a Patient With Postpolio Syndrome
Melodi Javid Whitley, MD, PhD, Willis Barrow, MD et. al.

Nov 25th, 2019 - Kaposi sarcoma (KS) is a low-grade vascular tumor that is rare among the general US population, with an incidence rate of less than 1 per 100,000. 1 The tumor is more common among certain groups of individuals due to geographic differences in the p.

see more →

Patient Education  5 results see all →